Literature DB >> 27596109

Clinical approach to diffuse large B cell lymphoma.

Paolo F Caimi1, Brian T Hill2, Eric D Hsi3, Mitchell R Smith4.   

Abstract

Diffuse large B cell lymphoma (DLBCL) is the most common subtype of lymphoma. We now recognize that DLBCL corresponds to a biologically heterogeneous family of diseases. Given the potential for cure for most DLBCL patients, appropriate diagnostic and staging evaluation and therapy are essential. Here we review areas of consensus as well as controversy in the evaluation, treatment and monitoring of patients with DLBCL and its related subtypes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autologous stem cell transplant; Chemotherapy; Diffuse large B cell lymphoma (DLBCL); Novel targeted therapy for lymphoma

Mesh：

Year:  2016        PMID： 27596109     DOI： 10.1016/j.blre.2016.06.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN： 0268-960X            Impact factor:   8.250


  12 in total

Review 1.  The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma.

Authors:  Rachel Hu; Allison Winter; Brian T Hill
Journal:  Curr Oncol Rep       Date:  2019-04-02       Impact factor: 5.075

2.  Diffuse large B-cell lymphoma: morphologic and immunohistochemical analysis of bone marrow for staging, with emphasis on lymphoid aggregates.

Authors:  Vinicius C Nóbrega; Maria A C Domingues; Lígia Niero-Melo; Cristiano C Oliveira
Journal:  Int J Clin Exp Pathol       Date:  2022-09-15

3.  Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters.

Authors:  Zsombor Ritter; László Papp; Katalin Zámbó; Zoltán Tóth; Dániel Dezső; Dániel Sándor Veres; Domokos Máthé; Ferenc Budán; Éva Karádi; Anett Balikó; László Pajor; Árpád Szomor; Erzsébet Schmidt; Hussain Alizadeh
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  Prognosis of Intravascular Large B Cell Lymphoma (IVLBCL): Analysis of 182 Patients from Global Case Series.

Authors:  Ziyue Liu; Yuelun Zhang; Yicheng Zhu; Wei Zhang
Journal:  Cancer Manag Res       Date:  2020-10-23       Impact factor: 3.989

Review 5.  FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Authors:  Sally F Barrington; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

6.  Primary esophageal diffuse large B cell lymphoma presenting with tracheoesophageal fistula: A rare case and review.

Authors:  Jirapat Teerakanok; Judy Park DeWitt; Edna Juarez; Kyaw Zin Thein; Irfan Warraich
Journal:  World J Gastrointest Oncol       Date:  2017-10-15

7.  Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL.

Authors:  Yocanxóchitl Perfecto-Avalos; Alejandro Garcia-Gonzalez; Ana Hernandez-Reynoso; Gildardo Sánchez-Ante; Carlos Ortiz-Hidalgo; Sean-Patrick Scott; Rita Q Fuentes-Aguilar; Ricardo Diaz-Dominguez; Grettel León-Martínez; Verónica Velasco-Vales; Mara A Cárdenas-Escudero; José A Hernández-Hernández; Arturo Santos; José R Borbolla-Escoboza; Luis Villela
Journal:  J Transl Med       Date:  2019-06-11       Impact factor: 5.531

8.  Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model.

Authors:  Floriana Cremasco; Elena Menietti; Dario Speziale; Johannes Sam; Stefano Sammicheli; Marine Richard; Ahmet Varol; Christian Klein; Pablo Umana; Marina Bacac; Sara Colombetti; Mario Perro
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

9.  Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma.

Authors:  Xin Xu; Ting Wei; Weijie Zhong; Rosalind Ang; Ye Lei; Hui Zhang; Qingshan Li
Journal:  Cancer Cell Int       Date:  2021-04-07       Impact factor: 5.722

10.  Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.

Authors:  Zhixing Kuang; Xun Li; Rongqiang Liu; Shaoxing Chen; Jiannan Tu
Journal:  Front Cell Dev Biol       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.